Capricor Therapeutics Inc.

NASDAQ: CAPR
Share price (12/24/24): $14.01
Market cap (12/24/24): $637 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Shelf registration – amended

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Highbridge Capital Management LLC

News Filter

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Pricing of Approximately $75 Million Public Offering of Common Stock

Earnings Release or Operating Update, Other Events

Announces Initiation of Rolling Submission of Biologics License Application (BLA) With U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC